Key facts
- Notable investors include Global Brain, Mirai Cross, Hiroshima Venture Capital, Aichi Capital, Central Japan Startup Ecosystem — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Olive (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Olive (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Olive (Healthcare Technology Systems)
Developer of an emotion recognition technology designed to facilitate communication and connect hearts and minds. The company's social networking platform offers an emotion analysis tool that combines biometric data such as heart rate and respiration, actions and facial expressions, enabling users to have a deeper understanding of human emotions in real-time and visualize and share these insights for personal development and social interaction.
- Sector
- Healthcare
- HQ
- Nagoya, Japan
- Founded
- 2022
- Employees
- 14
- Website
- 01ive.co.jp/
- Ownership
- Privately Held (backing)
Olive (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Olive (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Olive (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.